Purification and characterization of a major human Pneumocystis carinii surface antigen - PubMed (original) (raw)
Purification and characterization of a major human Pneumocystis carinii surface antigen
B Lundgren et al. J Clin Invest. 1991 Jan.
Abstract
Previous studies of Pneumocystis carinii have identified the major surface antigen of rat and human isolates as proteins of 116,000 and 95,000 mol wt, respectively, that are antigenically not identical. In this study both rat and human P. carinii proteins were purified by solubilization with zymolyase followed by molecular sieve and ion exchange chromatography. The native proteins had an apparent mol wt of 290,000 or greater, based on molecular sieve studies as well as cross-linking studies. Both proteins were glycoproteins; treatment with endoglycosidase H resulted in a 9% decrease in mol wt. The carbohydrate composition of the rat P. carinii glycoprotein was distinct from the human isolate; glucose, mannose, galactose, and glucosamine occurred in approximately equimolar ratios in the human P. carinii protein, whereas glucose and mannose were the predominant sugars of the rat P. carinii protein. To evaluate humoral immune responses to the human P. carinii protein, an enzyme-linked immunosorbent assay using purified protein was developed. Some, but not all, patients who subsequently developed P. carinii pneumonia demonstrated a serum antibody response to the surface antigen. Nearly all subjects without a history of P. carinii pneumonia had no detectable antibodies. Purified P. carinii proteins will greatly facilitate the investigation of host-P. carinii interactions.
Similar articles
- Identification of antigens and antibodies specific for Pneumocystis carinii.
Kovacs JA, Halpern JL, Swan JC, Moss J, Parrillo JE, Masur H. Kovacs JA, et al. J Immunol. 1988 Mar 15;140(6):2023-31. J Immunol. 1988. PMID: 3257995 - Cell wall antigens of Pneumocystis carinii trophozoites and cysts: purification and carbohydrate analysis of these glycoproteins.
De Stefano JA, Myers JD, Du Pont D, Foy JM, Theus SA, Walzer PD. De Stefano JA, et al. J Eukaryot Microbiol. 1998 May-Jun;45(3):334-43. doi: 10.1111/j.1550-7408.1998.tb04545.x. J Eukaryot Microbiol. 1998. PMID: 9627993 - Glycosylation of the major human Pneumocystis carinii surface antigen.
Lundgren B, Koch C, Mathiesen L, Nielsen JO, Hansen JE. Lundgren B, et al. APMIS. 1993 Mar;101(3):194-200. APMIS. 1993. PMID: 8507456 - Antigenic characterization of Pneumocystis carinii.
Gigliotti F, Haidaris CG. Gigliotti F, et al. Semin Respir Infect. 1998 Dec;13(4):313-22. Semin Respir Infect. 1998. PMID: 9872628 Review. - Alveolar macrophage and glycoprotein responses to Pneumocystis carinii.
Limper AH. Limper AH. Semin Respir Infect. 1998 Dec;13(4):339-47. Semin Respir Infect. 1998. PMID: 9872631 Review.
Cited by
- CD40 Expression by B Cells Is Required for Optimal Immunity to Murine Pneumocystis Infection.
Sassi M, Curran SJ, Bishop LR, Liu Y, Kovacs JA. Sassi M, et al. J Infect Dis. 2024 Oct 16;230(4):1033-1041. doi: 10.1093/infdis/jiae133. J Infect Dis. 2024. PMID: 38478734 Free PMC article. - CD40 Expression by B cells is Required for Optimal Immunity to Murine Pneumocystis Infection.
Sassi M, Curran SJ, Bishop LR, Liu Y, Kovacs JA. Sassi M, et al. bioRxiv [Preprint]. 2024 Feb 5:2024.02.05.578900. doi: 10.1101/2024.02.05.578900. bioRxiv. 2024. PMID: 38410485 Free PMC article. Updated. Preprint. - Pneumocystis carinii Major Surface Glycoprotein Dampens Macrophage Inflammatory Responses to Fungal β-Glucan.
Kottom TJ, Hebrink DM, Carmona EM, Limper AH. Kottom TJ, et al. J Infect Dis. 2020 Sep 1;222(7):1213-1221. doi: 10.1093/infdis/jiaa218. J Infect Dis. 2020. PMID: 32363390 Free PMC article. - Pathogenic Fungal Infection in the Lung.
Li Z, Lu G, Meng G. Li Z, et al. Front Immunol. 2019 Jul 3;10:1524. doi: 10.3389/fimmu.2019.01524. eCollection 2019. Front Immunol. 2019. PMID: 31333658 Free PMC article. Review. - Is the unique camouflage strategy of Pneumocystis associated with its particular niche within host lungs?
Hauser PM. Hauser PM. PLoS Pathog. 2019 Jan 24;15(1):e1007480. doi: 10.1371/journal.ppat.1007480. eCollection 2019 Jan. PLoS Pathog. 2019. PMID: 30677096 Free PMC article. Review. No abstract available.
References
- Nature. 1970 Aug 15;227(5259):680-5 - PubMed
- J Clin Microbiol. 1985 Dec;22(6):1058-60 - PubMed
- Infect Immun. 1973 Sep;8(3):317-21 - PubMed
- J Infect Dis. 1977 Jul;136(1):43-9 - PubMed
- J Exp Med. 1978 Jan 1;147(1):157-70 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources